510(k) K973101
K973101 is an FDA 510(k) premarket notification submitted by Dade Chemistry Systems, Inc. for the device "PROSTATE SPECIFIC ANTIGEN METHOD". The FDA issued a decision of Substantially Equivalent on Sep 18, 1997. The device falls under product code LTJ (Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers), a Class II device regulated under 21 CFR 866.6010. Dade Chemistry Systems, Inc. has 12 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Sep 18, 1997
- Date Received
- Aug 19, 1997
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers
- Device Class
- Class II
- Regulation Number
- 866.6010
- Review Panel
- IM
- Submission Type
- 510(k)
Need the full FDA record for Dade Chemistry Systems, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.